SCHEMBL3370622

SCHEMBL3370622

COc1cccc(-c2nnc(C3CCCN3OC(=O)NCc3ccc(F)cc3)o2)c1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.50
HCRTR1 O43613 1/20 0.49
HCRTR2 O43614 1/20 0.49
ALDH1A1 P00352 4/20 0.46
GAA P10253 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
MAPT P10636 1/20 0.42
PKM P14618 1/20 0.42
TNKS O95271 1/20 0.42
PARP1 P09874 1/20 0.42
PARP2 Q9UGN5 1/20 0.42
KDM4E B2RXH2 2/20 0.42
POLB P06746 1/20 0.42
ADCY1 Q08828 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
TP53 P04637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3368153 0.82 HCRTR1 (0.58) TSHRHCRTR1HCRTR2ALDH1A1GAA
SCHEMBL3366784 0.78 HCRTR1 (0.65) HCRTR1HCRTR2
SCHEMBL3368150 0.75 HCRTR1 (0.67) HCRTR1HCRTR2ALDH1A1MAPTKDM4E
SCHEMBL3367915 0.74 HCRTR1 (0.62) TSHRHCRTR1HCRTR2ALDH1A1GAA
SCHEMBL3368078 0.72 HCRTR1 (0.61) HCRTR1HCRTR2ALDH1A1SMN1; SMN2MAPT
SCHEMBL3369692 0.72 HCRTR1 (0.59) TSHRHCRTR1HCRTR2ALDH1A1PKM
SCHEMBL3366658 0.72 HCRTR1 (0.59) TSHRHCRTR1HCRTR2ALDH1A1GAA
SCHEMBL3365296 0.72 HCRTR1 (0.68) HCRTR1HCRTR2MAPT
SCHEMBL3366720 0.71 HCRTR1 (0.65) HCRTR1HCRTR2ALDH1A1SMN1; SMN2KDM4E
SCHEMBL3366754 0.71 HCRTR1 (0.60) TSHRHCRTR1HCRTR2ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1532141-B1 2-PYRROLIDIN-2-YL- [1,3,4]-OXADIAZOLE DERIVATIVES AND THE USE OF THE SAME AS ANTIDEPRESSANTS GRUENENTHAL GMBH (DE) 2010-10-13 EP disclosed